- Home
- HUMA vs DERM Comparison
HUMA vs DERM Comparison
Compare HUMA & DERM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HUMA
- DERM
- Stock Information
- Founded
- HUMA 2004
- DERM 2014
- Country
- HUMA United States
- DERM United States
- Employees
- HUMA N/A
- DERM N/A
- Industry
- HUMA Biotechnology: Pharmaceutical Preparations
- DERM Biotechnology: Pharmaceutical Preparations
- Sector
- HUMA Health Care
- DERM Health Care
- Exchange
- HUMA Nasdaq
- DERM Nasdaq
- Market Cap
- HUMA 221.8M
- DERM 181.0M
- IPO Year
- HUMA N/A
- DERM 2021
- Fundamental
- Price
- HUMA $2.67
- DERM $8.06
- Analyst Decision
- HUMA Strong Buy
- DERM Strong Buy
- Analyst Count
- HUMA 7
- DERM 2
- Target Price
- HUMA $13.00
- DERM $10.00
- AVG Volume (30 Days)
- HUMA 5.4M
- DERM 103.3K
- Earning Date
- HUMA 05-13-2025
- DERM 05-14-2025
- Dividend Yield
- HUMA N/A
- DERM N/A
- EPS Growth
- HUMA N/A
- DERM N/A
- EPS
- HUMA N/A
- DERM N/A
- Revenue
- HUMA $517,000.00
- DERM $56,243,000.00
- Revenue This Year
- HUMA N/A
- DERM $29.83
- Revenue Next Year
- HUMA $896.45
- DERM $54.88
- P/E Ratio
- HUMA N/A
- DERM N/A
- Revenue Growth
- HUMA N/A
- DERM N/A
- 52 Week Low
- HUMA $1.15
- DERM $3.54
- 52 Week High
- HUMA $9.97
- DERM $8.24
- Technical
- Relative Strength Index (RSI)
- HUMA 69.67
- DERM 65.90
- Support Level
- HUMA $2.41
- DERM $6.55
- Resistance Level
- HUMA $2.88
- DERM $7.00
- Average True Range (ATR)
- HUMA 0.30
- DERM 0.63
- MACD
- HUMA 0.10
- DERM 0.13
- Stochastic Oscillator
- HUMA 87.43
- DERM 92.41
About HUMA Humacyte Inc.
Humacyte Inc is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries, and chronic conditions. Company's pipeline includes Vascular Trauma, PAD, Dailysis, Acellular Tissue Engineered Vessels, Advanced Organ Systems, Advanced Tissue Constructs.
About DERM Journey Medical Corporation
Journey Medical Corp is a commercial stage pharmaceutical company focused on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions. The company's current product portfolio includes eight FDA-approved prescription drugs for dermatological conditions that are marketed in the U.S. Some of the group's products are Qbrexza, Accutane, Amzeeq, Exelderm and others.